Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Cancer Discovery|February 13, 2021
Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug ConjugateKenji Iida, Amr H Abdelhamid Ahmed, Akiko Kawano Nagatsuma, et al.
BMC Medical Genomics|May 18, 2011
Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell linesSiew Hong Lam, Serene G P Lee, Chin Y Lin, et al.
BMC Infectious Diseases|September 7, 2004
Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003Vinsensius B Vega, Yijun Ruan, Jianjun Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patientsLynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
Stem Cells (Dayton, Ohio)|January 27, 2005
Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell stateChia Lin Wei, Takumi Miura, Paul Robson, et al.
Hepatology (Baltimore, Md.)|September 22, 2005
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profilingSuk Woo Nam, Jik Young Park, Adaikalavan Ramasamy, et al.
Breast Cancer Research : BCR|January 29, 2011
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancerYuqing Li, Yi Li, Sara Wedrén, et al.
Breast Cancer Research : BCR|November 11, 2005
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsYudi Pawitan, Judith Bjöhle, Lukas Amler, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 18, 2017
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapyMinan Wang, Li-Chin Yao, Mingshan Cheng, et al.
Cancer Research|July 5, 2002
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsivenessEna Wang, Lance D Miller, Galen A Ohnmacht, et al.
Pageof 19